268 related articles for article (PubMed ID: 30477461)
1. Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines.
Mohana S; Ganesan M; Rajendra Prasad N; Ananthakrishnan D; Velmurugan D
BMC Cancer; 2018 Nov; 18(1):1168. PubMed ID: 30477461
[TBL] [Abstract][Full Text] [Related]
2. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer.
Mohana S; Ganesan M; Agilan B; Karthikeyan R; Srithar G; Beaulah Mary R; Ananthakrishnan D; Velmurugan D; Rajendra Prasad N; Ambudkar SV
Mol Biosyst; 2016 Jul; 12(8):2458-70. PubMed ID: 27216424
[TBL] [Abstract][Full Text] [Related]
3. Chemosensitizing potential of andrographolide in P-glycoprotein overexpressing multidrug-resistant cancer cell lines.
Lakra DS; B P; N D; T D; G K; N RP
Nat Prod Res; 2024 Mar; 38(6):941-946. PubMed ID: 37144420
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
Kang Y; Zhang S; Cao W; Wan D; Sun L
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
[TBL] [Abstract][Full Text] [Related]
6. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
[TBL] [Abstract][Full Text] [Related]
7. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.
Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
Lee YK; Lin TH; Chang CF; Lo YL
PLoS One; 2013; 8(11):e82478. PubMed ID: 24303084
[TBL] [Abstract][Full Text] [Related]
9. Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols.
Suttana W; Mankhetkorn S; Poompimon W; Palagani A; Zhokhov S; Gerlo S; Haegeman G; Berghe WV
Mol Cancer; 2010 May; 9():99. PubMed ID: 20438634
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
[TBL] [Abstract][Full Text] [Related]
11. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide reverts multidrug resistance in KBCh
Lakra DS; Bharathiraja P; Dhanalakshmi T; Prasad NR
Cell Biochem Funct; 2024 Mar; 42(2):e3948. PubMed ID: 38379216
[TBL] [Abstract][Full Text] [Related]
13. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
14. Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance.
Ghandadi M; Valadan R; Mohammadi H; Akhtari J; Khodashenas S; Ashari S
Curr Pharm Des; 2019; 25(39):4192-4207. PubMed ID: 31721699
[TBL] [Abstract][Full Text] [Related]
15. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
16. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
[TBL] [Abstract][Full Text] [Related]
17. Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells.
Chong KY; Hsu CJ; Hung TH; Hu HS; Huang TT; Wang TH; Wang C; Chen CM; Choo KB; Tseng CP
Cancer Biol Ther; 2015; 16(1):149-59. PubMed ID: 25590413
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
[TBL] [Abstract][Full Text] [Related]
19. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
[TBL] [Abstract][Full Text] [Related]
20. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway.
Zhang H; Zhang X; Wu X; Li W; Su P; Cheng H; Xiang L; Gao P; Zhou G
Cancer Lett; 2012 Oct; 323(1):106-113. PubMed ID: 22484497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
